reaction

When Volume Matters, Immunoassay Systems Deliver

...rigeration promotes reagent stability. The devices reaction vessel loader provides capacity for up to three hours of continuous sample processing Integrated reagent packs contain all necessary assay-specific reagents in self-resealing bar-coded packs requiring no reagent preparation. Automatic onboard waste ...

Prothrombin Time Comes in Small (CLIA-Waived) Packages

...ause pre-incorporated iron particles in the strips reaction chamber to move. An endpoint is reached when the formation of a clot causes immobilization of these particles. The company says that the system includes one of the fastest coagulation meters available, with results available within one minute. The ha...

Rapid Flu Tests May Prove Especially Helpful This Season

... serology, rapid antigen testing, polymerase chain reaction (PCR) and immunofluorescence testing. All are time-consuming, however, in a year when time is especially important. Fortunately, three medical firms produce quick-results kits that have been CLIA-waived by the CDC for point-of-care use. With all of ...

Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results

... from plasma via filter, the plasma moves into the reaction chamber and reacts with fluorescent-conjugated antibodies to all three markers. After incubation, the sample-reagent mixture flows through the device detection lane where complexes of analyte and conjugates are captured. The level of fluorescence i...

Tight Glycemic Control in the ICU

... disposable microcuvette, which serves as pipette, reaction vessel, and measuring cuvette. Approximately 5 l blood is drawn into the cuvette cavity by capillary action and spontaneously mixed with dried reagents on the inner walls. The cuvette is then placed into the analyzer, the absorbance is measured, an...

The Past, Present and Future of HLA Typing

...obes to HLA loci amplified by the polymerase chain reaction (PCR), or by using PCR to amplify the HLA DNA dire...A typing technique is to use the PCR amplification reaction directly to detect HLA polymorphisms. In this technique, primers can be constructed specifically to...

Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer

...08 patients with head andneck cancer were infusion reaction (3%), cardiopulmonary arrest(2%), dermatologic tox...BITUX inmCRC clinical trials (N=774) were infusion reaction (3%),dermatologic toxicity (1%), interstitial lung disease (0.4%), fever(5%), sepsis (3%), kidney fa...

Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis

...nitis, otherwise known as hay fever, is anallergic reaction to airborne substances such as pollen that getinto the upper respiratory passages and cause the body to produceantibodies and release histamine. Histamine makes the upperrespiratory membranes swell and produce typical allergy symptomssuch as sneezing...

Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis

... in life. ADis characterized by a hypersensitivity reaction occurring in theskin that causes chronic inflammation and renders the skin dry,itchy and scaly. Irritants (e.g. wool, soap), allergens andemotional stress exacerbate disease symptoms and further triggerthe overactive immune system. There is no cure a...

New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants

...posure or re-exposure. If a severehypersensitivity reaction occurs, therapy with Synagis should bepermanently discontinued. If milder hypersensitivity reactionoccurs, caution should be used on re-administration of Synagis. In clinical trials, the most common adverse events occurring atleast 1 percent more fr...

An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes

... conducted under widely varyingconditions, adverse reaction rates observed in the clinical trials ofa drug cannot be directly compared to rates in the clinical trials ofanother drug and may not reflect the rates observed in practice. 6.1 Clinical Trials Experience In controlled clinical studies as both ...

Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes

... conducted under widely varyingconditions, adverse reaction rates observed in the clinical trials ofa drug cannot be directly compared to rates in the clinical trials ofanother drug and may not reflect the rates observed in practice. 6.1 Clinical Trials Experience In controlled clinical studies as both ...

Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia

...y of atrialfibrillation, and one moderate infusion reaction in a patient whoresponded to outpatient intervention). About Hematide Hematide is a novel synthetic, pegylated peptidic compound thatbinds to and activates the erythropoietin receptor. The product isbeing developed for treatment of anemia in patien...

Vical Licensee AnGes MG Announces Positive Results of Phase 3 Angiogenesis Trial in Japan

...Placebo: 13subjects) were evaluated. Adverse drug reaction were equally distributed between AMG0001group and placebo group. There were 8 SAEs in 6 subjects in the AMG0001 group (peripheralischemia, cerebella infarction, post procedural hematoma, prostatecancer, bladder perforation, acute renal failure, peri...

Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy

...ated with placebo in Period B had an acuteinfusion reaction during the first infusion of ORENCIA in Period C.There was one acute infusion reaction (palpebral edema, pruritusand rash) later during Period C. No deaths or malignant neoplasmswere repo...

International Movement Disorder Specialists Receive New Information About the Use of Once-Daily Azilect in the Treatment of Parkinson's Disease

...adequateto rule out the possibility of an untoward reaction from combiningAZILECT with antidepressants. Other ...ine as it could possibly result in a serious reaction such as coma or death. -- You should not take AZILECT with tramadol, methadone, propoxyphene, ...

Extensive Clinical Data on Erbitux Presented at the 2007 ASCO Annual Meeting

...08 patients with head andneck cancer were infusion reaction (3%), cardiopulmonary arrest(2%), dermatologic tox...BITUX inmCRC clinical trials (N=774) were infusion reaction (3%),dermatologic toxicity (1%), interstitial lung disease (0.4%), fever(5%), sepsis (3%), kidney fa...

Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients

...confirm a correlation between theincidence of skin reaction and response to treatment when patientsare treated...on on mCRC patients who experienced no ormild skin reaction when treated with the standard dose of Erbitux(250 mg/m2) for 3 weeks. The study showed that increas...

Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors

...eutropenia (16.4%), myalgia(15.9%), injection site reaction (13.6%), aggravated fatigue(12.7%) and malaise (10...neutropenia(16.4%),myalgia (15.9%), injection site reaction (13.6%), aggravatedfatigue (12.7%) and malaise (10.9%). Because treatment with Vidazais associated w...

Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)

... or laryngismus (5%), syncope (3%), allergic reaction (1%) or anaphylaxis (1%). -- These events were severe in 2% of patients. Death during infusion has been reported. Vascular Leak Syndrome: -- This syndrome, characterized by 2 or more of the following 3 symptoms (hypotension, edem...

Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting

...lls by the bone marrow) was the mostcommon adverse reaction associated with satraplatin therapy.Twenty-one percent of patients in the satraplatin arm experiencedgrade 3 or 4 thrombocytopenia; 14% had grade 3 or 4 leucopenia and21% had grade 3 or 4 neutropenia. Gastrointestinal disorders werethe most frequent ...

The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer

...ortive therapy. Drug-related deaths from this reaction have been reported * Eloxatin(R) may cause fetal harm when administered to a pregnant woman. Women of childbearing potential should be advised not to become pregnant while receiving Eloxatin(R). It is not known whether Eloxatin(R) o...

Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting

...lls by the bone marrow) was the mostcommon adverse reaction associated with satraplatin therapy.Twenty-one percent of patients in the satraplatin arm experiencedgrade 3 or 4 thrombocytopenia; 14% had grade 3 or 4 leucopenia and21% had grade 3 or 4 neutropenia. Gastrointestinal disorders werethe most frequent ...

Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer Treatment

...ients who have a history ofsevere hypersensitivity reaction to pemetrexed or to any otheringredient used in th...n Known hypersensitivity to GEMZAR. Anaphylactoid reaction hasbeen reported rarely. Warnings Infusion times of GEMZAR longer than 60 minutes and morefrequent...

Data to be Presented at ASCO 2007 Highlights sanofi-aventis Commitment to Cancer Care and Research

...rtive therapy. Drug-related deaths from this reaction have been reported -- Eloxatin(R) may cause fet... such asinfection, low blood-cell counts, allergic reaction and retentionof excess fluid (edema). Taxotere(R) in combination with cisplatin is indicated for th...

Schering-Plough Announces Hepatitis C Data Presentations at Digestive Disease Week (DDW) 2007 Annual Meeting

...inued, and includedinjection site inflammation and reaction (i.e., bruise, itchiness,irritation). Injection site pain was reported in 2 percent ofpatients receiving PEGINTRON. Alopecia (thinning of the hair) isalso often associated with alpha interferons includingPEGINTRON. Psychiatric adverse events, which ...

Positive results from placebo-controlled phase IIa study in patients suffering from house dust mite allergy

...tis and foodhypersensitivity. It is an exaggerated reaction by the patient’s immune system to a normallyharmless substance such as various environmental proteins present in pollen, dust mite faeces, orfood. According to the World Health Organization, more than 20% of the world population suffers fromall...

MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease

...posure or re-exposure. If a severehypersensitivity reaction occurs, therapy with Synagis should bepermanently discontinued. If milder hypersensitivity reactionoccurs, caution should be used on re-administration of Synagis. In clinical trials, the most common adverse events occurring atleast 1 percent more fr...

IR BioSciences Announces Promising Data from Study of Its Compound Homspera

...s theyenable the vaccine to induce a strong immune reaction in vaccinatedindividuals, helping to ensure adequate immunologicalprotection. The Homspera studies, being carried out by GenPhar, examine theimpact of vaccination with pieces of influenza viruses (a currentH5N1 "avian influenza" strain and from the ...

Cephalon Presents Positive Results for Fentora in Breakthrough Pain Associated with Neuropathic Conditions

...ned to provide early-onsetanalgesia via a chemical reaction that enhances fentanyl absorptionacross the inner lining of the cheek. Cephalon is pursuing clinicaldevelopment of FENTORA in breakthrough pain associated withconditions other than cancer, including chronic neuropathic pain,and expects to file a supp...

Randomized Phase III Trial Showed Erbitux Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients

...tecan arm:8.2% vs. irinotecan arm: 0.5%), infusion reaction (1.4% vs. 0.8%)and hypomagnesemia (3.3% vs. 0.4%)....08 patients with head andneck cancer were infusion reaction (3%), cardiopulmonary arrest(2%), dermatologic toxicity (2.5%), mucositis (6%), radiationdermatitis ...

Positive Results Prompt US National Cancer Institute to Make Gleevec Available To Patients in Post-Surgical Gist Study

...ndrome) have also been reported. In some cases,the reaction recurred upon rechallenge. Several postmarketingre... following resolution or improvement of thebullous reaction Dose adjustments may be necessary due to hepatotoxicity, othernonhematologic adverse events, or hem...

Gentium's Defibrotide Highlighted in Two Poster Presentations at American Association for Cancer Research Annual Meeting

...on was evaluated through real timepolymerase chain reaction (RT-PCR) of cDNA prepared from the twolines of MM cells treated with Defibrotide or saline. Heparanaseactivity was measured in MM cells treated with Defibrotide (at 50,100 and 150 (mu)g/ml) or saline for 24 hours by using aheparan-degrading enzyme ki...

Baraclude (entecavir) Therapy Resulted in Undetectable Levels of Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment

...s/mL, measured by acommon assay - polymerase chain reaction or PCR) and 83 percentachieved liver enzyme normalization (ALT less than or equal to1xULN) after 48 weeks of therapy. "This study showed that when treated again with BARACLUDE for 48weeks, patients achieved responses similar to those seen prior to...

Advanced Magnetics Announces Positive Results from Two Additional Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement Therapeutic

...ercocet. The patient experienced an anaphylactoid reaction with severe hypotension a few minutes after ferumoxytol administration, was treated with subcutaneous epinephrine and recovered without sequelae. * The single SAE attributed to the drug after placebo administration occurred ...

Schering-Plough Addresses Major Milestones and Challenges in Treatment of Patients With Chronic Hepatitis C

...inued, and includedinjection site inflammation and reaction (i.e., bruise, itchiness,irritation). Injection site pain was reported in 2 percent ofpatients receiving PEGINTRON. Alopecia (thinning of the hair) isalso often associated with alpha interferons includingPEGINTRON. Psychiatric adverse events, which ...

Data Available from Erbitux Phase III Study in First-Line Treatment of Advanced Pancreatic Cancer

...08 patients with head andneck cancer were infusion reaction (3%), cardiopulmonary arrest(2%), dermatologic tox...BITUX inmCRC clinical trials (N=774) were infusion reaction (3%),dermatologic toxicity (1%), interstitial lung disease (0.4%), fever(5%), sepsis (3%), kidney fa...

Survival Data Available From Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer

...08 patients with head andneck cancer were infusion reaction (3%), cardiopulmonary arrest(2%), dermatologic tox...BITUX inmCRC clinical trials (N=774) were infusion reaction (3%),dermatologic toxicity (1%), interstitial lung disease (0.4%), fever(5%), sepsis (3%), kidney fa...

Survival Data Available from Erbitux Study in First-Line Treatment of Advanced Head and Neck Cancer

...08 patients with head andneck cancer were infusion reaction (3%), cardiopulmonary arrest(2%), dermatologic tox...BITUX inmCRC clinical trials (N=774) were infusion reaction (3%),dermatologic toxicity (1%), interstitial lung disease (0.4%), fever(5%), sepsis (3%), kidney fa...

New Study Confirms Role for Pertussis Immunization of Entire Family in Reducing Infant Pertussis

... any component ofthe vaccine or a life-threatening reaction after previousadministration of the vaccine or a vaccine containing the samesubstances. Because of uncertainty as to which component of thevaccine may be responsible, no further vaccination with thediphtheria, tetanus, or pertussis components found i...

Aeolus Pharmaceuticals Announces Successful Completion of Multiple Dose Safety Study of AEOL 10150

...rseevents. The most common injection/infusion site reaction wasdiscoloration; other reactions included induration, erythema, andpain. Two (50%) of the subjects who received AEOL 10150 2 mg/kg/day(but none of the placebo subjects) via subcutaneous infusiondeveloped persistent lesions with ulceration and tissue...

Placebo-controlled Phase IIa Study with the Immunotherapeutic CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in Hay Fever Patients

...tis and foodhypersensitivity. It is an exaggerated reaction by thepatient’s immune system to a normally harmless substance suchas various environmental proteins present in pollen, animalexcrements, or food. According to the World Health Organization,more than 20% of the world population suffers from all...